Cardiff Oncology to Present at the Cowen 44th Annual Health Care ConferenceSAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a fireside chat and 1x1 investor meetings at the Cowen 44th Annual Health Care Conference, which is taking place at the Marriott Copley Place in Boston from March 4-6, 2024.
Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update- Management will hold a conference call on Thursday, February 29 at 4:30 p.m. ET/1:30 p.m. PT -
